MC1335A1 - Derives de l'acide dihydronicotinique,leur preparation et leur utilisation - Google Patents

Derives de l'acide dihydronicotinique,leur preparation et leur utilisation

Info

Publication number
MC1335A1
MC1335A1 MC801452A MC1452A MC1335A1 MC 1335 A1 MC1335 A1 MC 1335A1 MC 801452 A MC801452 A MC 801452A MC 1452 A MC1452 A MC 1452A MC 1335 A1 MC1335 A1 MC 1335A1
Authority
MC
Monaco
Prior art keywords
naphthyl
ethyl
acid
formula
carbon atoms
Prior art date
Application number
MC801452A
Other languages
English (en)
French (fr)
Inventor
A Wick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1335A1 publication Critical patent/MC1335A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08Preparation by ring-closure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MC801452A 1979-07-13 1980-06-11 Derives de l'acide dihydronicotinique,leur preparation et leur utilisation MC1335A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH655579 1979-07-13

Publications (1)

Publication Number Publication Date
MC1335A1 true MC1335A1 (fr) 1981-04-21

Family

ID=4311435

Family Applications (1)

Application Number Title Priority Date Filing Date
MC801452A MC1335A1 (fr) 1979-07-13 1980-06-11 Derives de l'acide dihydronicotinique,leur preparation et leur utilisation

Country Status (21)

Country Link
US (1) US4278798A (cs)
EP (1) EP0023593B1 (cs)
JP (1) JPS5615269A (cs)
KR (1) KR840001034B1 (cs)
AR (1) AR225447A1 (cs)
AT (1) ATE2520T1 (cs)
AU (1) AU537900B2 (cs)
CA (1) CA1125762A (cs)
DE (1) DE3062022D1 (cs)
DK (1) DK148082B (cs)
ES (1) ES8105712A1 (cs)
FI (1) FI802097A7 (cs)
GR (1) GR69304B (cs)
HU (1) HU180589B (cs)
IL (1) IL60513A (cs)
MC (1) MC1335A1 (cs)
NO (1) NO802099L (cs)
NZ (1) NZ194258A (cs)
PH (1) PH16046A (cs)
PT (1) PT71542B (cs)
ZA (1) ZA804079B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1110234A (en) * 1978-01-18 1981-10-06 Hoffmann-La Roche Limited 4-pyridone-3-carboxylic acids and process for the preparation thereof
US4649157A (en) * 1986-03-28 1987-03-10 G. D. Searle & Co. Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
US9988373B2 (en) 2013-12-26 2018-06-05 Shionogi & Co., Ltd. Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051142A (en) * 1976-05-24 1977-09-27 Rohm And Haas Company 1-Aryl-4-pyridones
EP0001041A3 (en) * 1977-07-27 1979-06-27 Sandoz Ag Alpha(pyridonecarboxylamino)-alpha substituted acetamido penicillins and -cephalosporins, process for their preparation, their use in pharmaceuticals; pyridones used in the process
CA1110234A (en) * 1978-01-18 1981-10-06 Hoffmann-La Roche Limited 4-pyridone-3-carboxylic acids and process for the preparation thereof

Also Published As

Publication number Publication date
PT71542B (en) 1981-12-14
DK287080A (da) 1981-01-14
ES493355A0 (es) 1981-06-16
AU6015380A (en) 1981-01-15
NZ194258A (en) 1984-07-06
US4278798A (en) 1981-07-14
FI802097A7 (fi) 1981-01-01
KR830003423A (ko) 1983-06-20
DK148082B (da) 1985-02-25
CA1125762A (en) 1982-06-15
JPS5615269A (en) 1981-02-14
EP0023593A1 (de) 1981-02-11
IL60513A (en) 1983-10-31
GR69304B (cs) 1982-05-14
AR225447A1 (es) 1982-03-31
DE3062022D1 (en) 1983-03-24
HU180589B (en) 1983-03-28
AU537900B2 (en) 1984-07-19
NO802099L (no) 1981-01-14
PT71542A (en) 1980-08-01
EP0023593B1 (de) 1983-02-16
IL60513A0 (en) 1980-09-16
PH16046A (en) 1983-06-02
ZA804079B (en) 1981-07-29
KR840001034B1 (ko) 1984-07-26
ES8105712A1 (es) 1981-06-16
ATE2520T1 (de) 1983-03-15

Similar Documents

Publication Publication Date Title
EP0389370B1 (fr) Nouveaux stéroides 19-Nor 3-céto comportant une chaîne en 17 aminosubstituée, leur procédé de préparation et les intermédiaires de ce procédé,leur application comme médicaments et les compositions pharmaceutiques les contenant
FR2555571A1 (fr) Derives du naphtalene, leur procede de preparation et leur application dans le domaine therapeutique
CH644365A5 (fr) Octahydro-pyrazolo(3,4-g)quinoleines.
FR2534257A1 (fr) Nouveaux derives de la 6-amino 7-hydroxy 4,5,6,7-tetrahydro-imidazo/4,5,1-j-k/ /1/ benzazepin-2(1h)-one, leurs sels, application a titre de medicaments, compositions les renfermant et un intermediaire
EP0110755B1 (fr) Dérivés de la pipéridinedione protecteurs du myocarde présentant une activité antiarythmique, leur procédé de préparation et les médicaments qui contiennent lesdits dérivés
EP0117771B1 (fr) Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique
EP0239461A1 (fr) Dérivés de N-¬¬(hydroxy-2 phényl) (phényl) méthylène amino-2 éthyl acétamide, leur préparation et leur application en thérapeutique
FR2584713A1 (fr) Nouveaux derives de l'indole carboxamide, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
EP0619807A1 (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
MC1338A1 (fr) Derives de sucres
FR2631827A1 (fr) Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
MC1335A1 (fr) Derives de l'acide dihydronicotinique,leur preparation et leur utilisation
BE897617A (fr) Thioesters d'acide acetylsalicylique procede pour les preparer et compositions pharmaceutiques qui en renferment
EP0173585B1 (fr) Médicaments à base de dérivés de la pipéridine, nouveaux dérivés de la pipéridine et leurs procédés de préparation
MC1387A1 (fr) Nouveaux derives de phenoxyaminopropanol et leur preparation
EP0294258A1 (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
EP0061379B1 (fr) Dérivés de pyridine, leur préparation et leur application en thérapeutique
CA1060020A (fr) Procede de preparation de nouveaux derives de la dibenzo/b,c/ thiepine et leurs sels
CH642961A5 (fr) Beta-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
EP0082059A1 (fr) Ethers d'oximes alpha-bêta insaturés, leur procédé de préparation et leur utilisation comme médicament
KR920002266B1 (ko) N-비사이클로헵틸- 및 n-비사이클로헵테닐-이미다졸의 제조방법
CA1161444A (fr) Procede de preparation de derives du cycloheptindolol et de leurs sels avec les acides
FR2556592A1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
EP0113600B1 (fr) Dérivés de la gamma-butyrolactone protecteurs du myocarde présentant une activité antiarythmique, procédé pour leur préparation et médicaments en contenant

Legal Events

Date Code Title Description
YP Annual fee paid